Safety and efficacy of temsirolimus as second-line treatment for patients with recurrent bladder cancer.

被引：0
|
作者：
Houede, Nadine
Roubaud, Guilhem
Mahammedi, Hakim
Vedrine, Lionel
Joly, Florence
Mourey, Loic
Pfister, Christian
Culine, Stephane
Goberna, Alejandro
Lortal, Barbara
Pulido, Marina
Pourquier, Philippe
Bellera, Carine A.
机构：
[1] Ctr Hosp Reg Univ, Nimes, France
[2] Inst Bergonie, Dept Med Oncol, Bordeaux, France
[3] Ctr Jean Perrin, Clermont Ferrand, France
[4] Val de Grace Hosp, Paris, France
[5] Ctr Francois Baclesse, Comite Urogynecol, F-14021 Caen, France
[6] Inst Claudius Regaud, Toulouse, France
[7] Ctr Hosp Rouen, Rouen, France
[8] Hop St Louis, Dept Med Oncol, Paris, France
[9] Inst Bergonie, Bordeaux, France
[10] INSERM, U916, Bordeaux, France
[11] Reg Comprehens Canc Ctr, Inst Bergonie, Bordeaux, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 07期
关键词：
D O I：
10.1200/jco.2015.33.7_suppl.304
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
304
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Safety and efficacy of temsirolimus as second line treatment for patients with recurrent bladder cancer
    Pulido, Marina
    Roubaud, Guilhem
    Cazeau, Anne-Laure
    Mahammedi, Hakim
    Vedrine, Lionel
    Joly, Florence
    Mourey, Loic
    Pfister, Christian
    Goberna, Alejandro
    Lortal, Barbara
    Bellera, Carine
    Pourquier, Philippe
    Houede, Nadine
    [J]. BMC CANCER, 2018, 18
  • [2] Safety and efficacy of temsirolimus as second line treatment for patients with recurrent bladder cancer
    Marina Pulido
    Guilhem Roubaud
    Anne-Laure Cazeau
    Hakim Mahammedi
    Lionel Vedrine
    Florence Joly
    Loic Mourey
    Christian Pfister
    Alejandro Goberna
    Barbara Lortal
    Carine Bellera
    Philippe Pourquier
    Nadine Houédé
    [J]. BMC Cancer, 18
  • [3] Re: Safety and Efficacy of Temsirolimus as Second Line Treatment for Patients with Recurrent Bladder Cancer
    Chang, Sam S.
    [J]. JOURNAL OF UROLOGY, 2019, 201 (06): : 1053 - 1053
  • [4] Safety and efficacy of Temsirolimus (Torisel®) as second line treatment for patients with recurrent bladder cancer
    Houede, N.
    Roubaud, G.
    Mahammedi, H.
    Vedrine, L.
    Joly, F.
    Mourey, L.
    Pfister, C.
    Culine, S.
    Goberna, A.
    Lortal, B.
    Pulido, M.
    Pourquier, P.
    Bellera, C.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S509 - S509
  • [5] Efficacy and safety of second-line fotemustine in elderly patients with recurrent glioblastoma
    Matteo Santoni
    Silvia Scoccianti
    Ivan Lolli
    Maria Grazia Fabrini
    Giovanni Silvano
    Beatrice Detti
    Franco Perrone
    Giuseppina Savio
    Roberto Iacovelli
    Luciano Burattini
    Rossana Berardi
    Stefano Cascinu
    [J]. Journal of Neuro-Oncology, 2013, 113 : 397 - 401
  • [6] Efficacy and safety of second-line fotemustine in elderly patients with recurrent glioblastoma
    Santoni, Matteo
    Scoccianti, Silvia
    Lolli, Ivan
    Fabrini, Maria Grazia
    Silvano, Giovanni
    Detti, Beatrice
    Perrone, Franco
    Savio, Giuseppina
    Iacovelli, Roberto
    Burattini, Luciano
    Berardi, Rossana
    Cascinu, Stefano
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2013, 113 (03) : 397 - 401
  • [7] Efficacy and safety of paclitaxel/ramucirumab as the second-line chemotherapy in Japanese patients with advanced gastric cancer.
    Kusumoto, Tetsuya
    Egashira, Akinori
    Sonoda, Hideto
    Hashimoto, Kenkichi
    Uehara, Hideo
    Kusumoto, Eiji
    Shinzato, Chiaki
    Uchino, Keita
    Sakaguchi, Yoshihisa
    Ikejiri, Koji
    Maehara, Yoshihiko
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [8] Safety and efficacy of eribulin as second-line treatment for HER2-negative metastatic breast cancer.
    Michalaki, Vasiliki
    Psychogios, John
    Contis, John
    Kondi, Agathi
    Gennatas, Constantine
    Papadimitriou, Christos A.
    Vasiliou, John
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] Investigation of prognostic factors for second-line treatment with nivolumab for unresectable or recurrent esophageal cancer.
    Ogata, Takashi
    Machida, Nozomu
    Takahashi, Kosuke
    Kano, Kazuki
    Koumori, Keisuke
    Watanabe, Hayato
    Fujikawa, Hirohito
    Yamada, Takanobu
    Inokuchi, Yasuhiro
    Furuta, Mitsuhiro
    Kaneta, Yoshihiro
    Hayashi, Kei
    Ishida, Ayaka
    Oshima, Takashi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [10] Second-line chemotherapy in patients with biliary tract cancer.
    Brandi, G.
    Di Girolamo, S.
    de Rosa, F.
    Corbelli, J.
    Agostini, V.
    Garajova, I.
    Longobardi, C.
    Paragona, M.
    Ercolani, G.
    Pinna, A. D.
    Biasco, G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345